These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2989593)

  • 1. [Plasma angiotensin I converting enzyme and renin angiotensin aldosterone system in hypertensive subjects].
    Nakamura M; Otokida K; Kanazawa S; Kato M
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):97-102. PubMed ID: 2989593
    [No Abstract]   [Full Text] [Related]  

  • 2. [The behavior of serum angiotensin-converting enzyme in normotensive subjects, in subjects with essential hypertension and in subjects with primary hyperaldosteronism on the orthostatic test].
    Letizia C; Cerci S; De Ciocchis A; Tarsitani P; D'Ambrosio C; Coassin S; Scavo D
    Minerva Cardioangiol; 1992 Dec; 40(12):505-11. PubMed ID: 1338343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma angiotensin I converting enzyme in regulation of renin-angiotensin system activity in patients with essential hypertension.
    Ishida H; Shimamoto K; Ando T; Nishitani T; Hosoda S; Yokoyama T; Fukuyama S; Mori Y; Nakagawa H; Ogata H
    J Clin Hypertens; 1987 Dec; 3(4):681-4. PubMed ID: 2839630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin, aldosterone, and serum-converting enzyme activity during normal and hypertensive pregnancy.
    Dux S; Yaron A; Carmel A; Rosenfeld JB
    Gynecol Obstet Invest; 1984; 17(5):252-7. PubMed ID: 6329926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin-aldosterone system in pregnancy-induced hypertension.
    Israel A; Peceño A
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S36-9. PubMed ID: 10854079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-angiotensin-aldosterone system in thyroid disorders].
    Marcisz C
    Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin-angiotensin-aldosterone system in chronic poisoning of rats with lead and cadmium].
    Skoczyńska A
    Med Pr; 1995; 46(3):239-46. PubMed ID: 7565072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of angiotensin-converting enzyme in women with hyperthyroidism accompanying Graves-Basedow disease].
    Zdrojewicz Z
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1004-5. PubMed ID: 1339053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin-aldosterone system in brain infarction and vascular death.
    Brenner D; Labreuche J; Poirier O; Cambien F; Amarenco P;
    Ann Neurol; 2005 Jul; 58(1):131-8. PubMed ID: 15984009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral effects of ACE-inhibition.
    Cerasola G; Cottone S; Grasso L; D'Ignoto G; Carone MB; Carapelle E; Fulantelli MA; Contorno A
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):195-200. PubMed ID: 2820442
    [No Abstract]   [Full Text] [Related]  

  • 17. The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with the circadian cycle of plasma renin and aldosterone.
    Cugini P; Letizia C; Scavo D
    Chronobiologia; 1988; 15(3):229-31. PubMed ID: 2853037
    [No Abstract]   [Full Text] [Related]  

  • 18. Amlodipine in ambulatory hypertensive patients: humoral and haemodynamic effects.
    Letizia C; De Ciocchis A; Cerci S; Coassin S; Fisher H; Tarsitani P; Scavo D
    Int J Clin Pharmacol Res; 1993; 13(3):151-9. PubMed ID: 8225698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heritability of plasma renin activity and plasma concentration of angiotensinogen and angiotensin-converting enzyme.
    Vinck WJ; Fagard RH; Vlietinck R; Lijnen P
    J Hum Hypertens; 2002 Jun; 16(6):417-22. PubMed ID: 12037697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].
    Hory B; Henriet MT
    Nephrologie; 1983; 4(4-5):229-30. PubMed ID: 6320023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.